|Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers|
H Shigematsu, L Lin, T Takahashi, M Nomura, M Suzuki, II Wistuba, ...
Journal of the National Cancer Institute 97 (5), 339-346, 2005
|Phases of biomarker development for early detection of cancer|
MS Pepe, R Etzioni, Z Feng, JD Potter, ML Thompson, M Thornquist, ...
Journal of the National Cancer Institute 93 (14), 1054-1061, 2001
|Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study|
JL Stanford, Z Feng, AS Hamilton, FD Gilliland, RA Stephenson, JW Eley, ...
Jama 283 (3), 354-360, 2000
|Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men|
BL Adam, Y Qu, JW Davis, MD Ward, MA Clements, LH Cazares, ...
Cancer research 62 (13), 3609-3614, 2002
|Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial|
IM Thompson, DP Ankerst, C Chi, PJ Goodman, CM Tangen, MS Lucia, ...
Journal of the National Cancer Institute 98 (8), 529-534, 2006
|Association between body-mass index and risk of death in more than 1 million Asians|
W Zheng, DF McLerran, B Rolland, X Zhang, M Inoue, K Matsuo, J He, ...
New England Journal of Medicine 364 (8), 719-729, 2011
|α-fetoprotein, des-γ carboxyprothrombin, and lectin-bound α-fetoprotein in early hepatocellular carcinoma|
JA Marrero, Z Feng, Y Wang, MH Nguyen, AS Befeler, LR Roberts, ...
Gastroenterology 137 (1), 110-118, 2009
|5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study|
DF Penson, D McLERRAN, Z Feng, L Li, PC Albertsen, FD Gilliland, ...
The Journal of urology 173 (5), 1701-1705, 2005
|Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design|
MS Pepe, Z Feng, H Janes, PM Bossuyt, JD Potter
Journal of the National Cancer Institute 100 (20), 1432-1438, 2008
|Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients|
Y Qu, BL Adam, Y Yasui, MD Ward, LH Cazares, PF Schellhammer, ...
Clinical chemistry 48 (10), 1835-1843, 2002
|Diagnostic markers for early detection of ovarian cancer|
I Visintin, Z Feng, G Longton, DC Ward, AB Alvero, Y Lai, J Tenthorey, ...
Clinical cancer research 14 (4), 1065-1072, 2008
|Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of …|
OJ Semmes, Z Feng, BL Adam, LL Banez, WL Bigbee, D Campos, ...
Clinical Chemistry 51 (1), 102-112, 2005
|Optimizing endoscopic biopsy detection of early cancers in Barrett’s high-grade dysplasia|
BJ Reid, PL Blount, Z Feng, DS Levine
The American journal of gastroenterology 95 (11), 3089-3096, 2000
|Associations of race/ethnicity, education, and dietary intervention with the validity and reliability of a food frequency questionnaire: the Women's Health Trial Feasibility …|
AR Kristal, Z Feng, RJ Coates, A Oberman, V George
American journal of epidemiology 146 (10), 856-869, 1997
|Smoke exposure, histologic type and geography‐related differences in the methylation profiles of non‐small cell lung cancer|
S Toyooka, R Maruyama, KO Toyooka, D McLerran, Z Feng, Y Fukuyama, ...
International journal of cancer 103 (2), 153-160, 2003
|A data‐analytic strategy for protein biomarker discovery: profiling of high‐dimensional proteomic data for cancer detection|
Y Yasui, M Pepe, ML Thompson, BL Adam, GL Wright Jr, Y Qu, JD Potter, ...
Biostatistics 4 (3), 449-463, 2003
|Identification of osteopontin as a novel marker for early hepatocellular carcinoma|
S Shang, A Plymoth, S Ge, Z Feng, HR Rosen, S Sangrajrang, P Hainaut, ...
Hepatology 55 (2), 483-490, 2012
|Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort Consortium|
Y Chen, WK Copeland, R Vedanthan, E Grant, JE Lee, D Gu, PC Gupta, ...
Bmj 347, 2013
|Integrating the predictiveness of a marker with its performance as a classifier|
MS Pepe, Z Feng, Y Huang, G Longton, R Prentice, IM Thompson, ...
American journal of epidemiology 167 (3), 362-368, 2008
|Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk|
K Schulmann, A Sterian, A Berki, J Yin, F Sato, Y Xu, A Olaru, S Wang, ...
Oncogene 24 (25), 4138-4148, 2005